Clinical Trials

Permanent URI for this collection

Now showing 1 - 1 of 1

Efficacy and Saftey of Artemether-Lumefantrine with Single Dose Primaquine for Treatment of Uncomplicated Plasmodium Falciparum Malaria in Arbaminch, Southwest Ethiopia
(Addis Ababa University, 2024-04-13) Bontu Abate; Eyasu Makonnen
In Ethiopia, 60% of the population resides in areas prone to malaria infection. The first-line treatment for uncomplicated Plasmodium falciparum (P. falciparum) infection in Ethiopia is artemether-lumefantrine (AL), as outlined in the national malaria diagnosis and treatment guideline. The World Health Organization (WHO) recommends monitoring the efficacy of first-line antimalarial drugs at least once every two years post-implementations. Such information is crucial for assessing resistance levels and implementing timely interventions